Success Metrics

Active Trials
3(75%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Active, not recruiting2
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting250%
recruiting125%
enrolling_by_invitation125%

Recent Activity

3 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

SmartWatch-driven AF Detection in Stroke Patients

NCT06832579
enrolling_by_invitationnot_applicable

Wearable Integration in Symptom Evaluation for Cancer Survivors

NCT07463547
active_not_recruitingnot_applicable

Physiological Reaction After Food Intake

NCT06548165
recruiting

High Definition Medicine for Solid Tumors Oncology

NCT06590506

Clinical Trials (4)

Showing 4 of 4 trials
NCT06832579Not Applicable

SmartWatch-driven AF Detection in Stroke Patients

Active Not Recruiting
NCT07463547Not Applicable

Wearable Integration in Symptom Evaluation for Cancer Survivors

Enrolling By Invitation
NCT06548165Not Applicable

Physiological Reaction After Food Intake

Active Not Recruiting
NCT06590506

High Definition Medicine for Solid Tumors Oncology

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4